IR@PKUHSC  > 北京大学基础医学院
学科主题基础医学
Intermedin inhibits vascular calcification by increasing the level of matrix gamma-carboxyglutamic acid protein
Cai, Yan1; Xu, Ming-Jiang1; Teng, Xu1; Zhou, Ye Bo1; Chen, Li2; Zhu, Yi1,2; Wang, Xian1,2; Tang, Chao Shu1,2; Qi, Yong Fen1,2,3
关键词Vascular Calcification Peptides Matrix Gamma-carboxyglutamic (Gla) Protein Phenotype Transition
刊名CARDIOVASCULAR RESEARCH
2010-03-01
DOI10.1093/cvr/cvp366
85期:4页:864-873
收录类别SCI
文章类型Article
WOS标题词Science & Technology
类目[WOS]Cardiac & Cardiovascular Systems
研究领域[WOS]Cardiovascular System & Cardiology
关键词[WOS]SMOOTH-MUSCLE-CELLS ; BONE MORPHOGENETIC PROTEIN-2 ; VITAMIN-D-3 PLUS NICOTINE ; HORMONE-RELATED PEPTIDE ; CHRONIC KIDNEY-DISEASE ; GLA PROTEIN ; ARTERIAL CALCIFICATION ; IN-VITRO ; PARATHYROID-HORMONE ; PROTECTIVE FACTOR
英文摘要

Vascular calcification (VC) is highly associated with increased morbidity and mortality in patients with advanced chronic kidney disease. Paracrine/autocrine factors such as vasoactive peptides are involved in VC development. Here, we investigated the expression of the novel peptide intermedin (IMD) in the vasculature, tested its ability to prevent VC in vivo and in vitro, and examined the mechanism involved.

Rat VC was induced by administration of vitamin D-3 plus nicotine (VDN). IMD (100 ng kg(-1) h(-1)) was systemically administered by a mini-osmotic pump. VDN-treated rat aortas showed lower IMD content and increased expression of its receptors, along with increased vascular calcium deposition and alkaline phosphatase (ALP) activity. Low IMD levels were accompanied by increased calcium deposition in human atherosclerotic plaques. In vivo administration of IMD greatly reduced vascular calcium deposition and ALP activity in VDN-treated rats when compared with vehicle treatment, which was further confirmed in cultured vascular smooth muscle cells. Concurrently, the loss of smooth-muscle lineage markers and matrix gamma-carboxyglutamic acid (Gla) protein (cMGP) in aortas was ameliorated by administering IMD to rats with VC, and the increased phosphor-Smad(1/5/8) and core binding factor alpha-1 levels in calcified vasculature were also reduced. However, the inhibitory effects of IMD on VC were eliminated upon pre-treatment with warfarin or small interfering RNA to reduce cMGP.

Reduced endogenous IMD levels are associated with increased mineralization in vivo, and administration of IMD inhibits VC development by increasing cMGP levels. IMD may be an endogenous vasoprotective factor for VC.

语种英语
WOS记录号WOS:000274487900026
项目编号30470693 ; 30770869 ; 30871013 ; 2006CB503807
资助机构National Natural Science Foundation of China ; State Major Basic Research Development Program of the People&prime ; s Republic of China
引用统计
被引频次:35[WOS]   [WOS记录]     [WOS相关记录]
文献类型期刊论文
条目标识符http://ir.bjmu.edu.cn/handle/400002259/55017
专题北京大学基础医学院
作者单位1.Peking Univ, Dept Physiol & Pathophysiol, Hlth Sci Ctr, Beijing 100191, Peoples R China
2.Minist Educ Res, Key Lab Mol Cardiovasc Sci, Beijing 100191, Peoples R China
3.Peking Univ, Sch Basic Med Sci, Lab Cardiovasc Bioact Mol, Beijing 100191, Peoples R China
推荐引用方式
GB/T 7714
Cai, Yan,Xu, Ming-Jiang,Teng, Xu,et al. Intermedin inhibits vascular calcification by increasing the level of matrix gamma-carboxyglutamic acid protein[J]. CARDIOVASCULAR RESEARCH,2010,85(4):864-873.
APA Cai, Yan.,Xu, Ming-Jiang.,Teng, Xu.,Zhou, Ye Bo.,Chen, Li.,...&Qi, Yong Fen.(2010).Intermedin inhibits vascular calcification by increasing the level of matrix gamma-carboxyglutamic acid protein.CARDIOVASCULAR RESEARCH,85(4),864-873.
MLA Cai, Yan,et al."Intermedin inhibits vascular calcification by increasing the level of matrix gamma-carboxyglutamic acid protein".CARDIOVASCULAR RESEARCH 85.4(2010):864-873.
条目包含的文件
条目无相关文件。
个性服务
推荐该条目
保存到收藏夹
查看访问统计
导出为Endnote文件
谷歌学术
谷歌学术中相似的文章
[Cai, Yan]的文章
[Xu, Ming-Jiang]的文章
[Teng, Xu]的文章
百度学术
百度学术中相似的文章
[Cai, Yan]的文章
[Xu, Ming-Jiang]的文章
[Teng, Xu]的文章
必应学术
必应学术中相似的文章
[Cai, Yan]的文章
[Xu, Ming-Jiang]的文章
[Teng, Xu]的文章
相关权益政策
暂无数据
收藏/分享
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。